Back to search

Peptide record

TPDB09475

Antibacterial Anticancer Toxicity standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09475
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 20-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GIKIAKKAITIAKKIAKIYW
Physicochemical Analysis
C110H189N27O23
RNDCEQHLMFPSV
IK
2257.88
10.87
6
0
12
+6
0.76
0.375
137.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
6990
309.58
2
Residue Composition
number
4
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
6
I
0
L
6
K
0
M
0
F
0
P
0
S
1
T
1
W
1
Y
0
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 6 L: 0 K: 6 M: 0 F: 0 P: 0 S: 0 T: 1 W: 1 Y: 1 V: 0
Chemical Descriptors
20
C110H189N27O23
2257.88
10.87
+6
0.76
0.375
Evidence Records 2 records
Evidence 1 Activity

Activity

<5% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
<5% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. | Int J Antimicrob Agents | 2008
Evidence 2 Activity

Activity

MHC
Toxicity
128 µM
Hemolytic
Hemolytic_activity: [Ref.18586467] MHC=128 µM against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Int J Antimicrob Agents. 2008 Aug 32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.